15-63601438-G-A
Variant summary
Our verdict is Uncertain significance. Variant got 0 ACMG points: 2P and 2B. PM2BP4_Moderate
The NM_203373.3(FBXL22):c.496G>A(p.Ala166Thr) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000203 in 1,426,920 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 14/20 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★). Synonymous variant affecting the same amino acid position (i.e. A166A) has been classified as Likely benign.
Frequency
Consequence
NM_203373.3 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 0 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
FBXL22 | NM_203373.3 | c.496G>A | p.Ala166Thr | missense_variant | 2/2 | NP_976307.2 | ||
FBXL22 | NM_001367809.1 | c.*146G>A | 3_prime_UTR_variant | 3/3 | NP_001354738.1 | |||
FBXL22 | XM_047432400.1 | c.353+3693G>A | intron_variant | XP_047288356.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
FBXL22 | ENST00000360587.2 | c.496G>A | p.Ala166Thr | missense_variant | 2/2 | 1 | ENSP00000353794.3 | |||
FBXL22 | ENST00000560325.1 | c.*146G>A | 3_prime_UTR_variant | 3/3 | 3 | ENSP00000473666.1 | ||||
USP3-AS1 | ENST00000561256.5 | n.152C>T | non_coding_transcript_exon_variant | 1/3 | 3 |
Frequencies
GnomAD3 genomes Cov.: 32
GnomAD3 exomes AF: 0.0000144 AC: 3AN: 208900Hom.: 0 AF XY: 0.00000868 AC XY: 1AN XY: 115196
GnomAD4 exome AF: 0.0000203 AC: 29AN: 1426920Hom.: 0 Cov.: 32 AF XY: 0.0000241 AC XY: 17AN XY: 706024
GnomAD4 genome Cov.: 32
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Aug 26, 2022 | The c.496G>A (p.A166T) alteration is located in exon 2 (coding exon 2) of the FBXL22 gene. This alteration results from a G to A substitution at nucleotide position 496, causing the alanine (A) at amino acid position 166 to be replaced by a threonine (T). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at